Hemangioma secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 15: Line 15:
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Oncology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 17:53, 22 August 2015

Hemangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hemangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hemangioma secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hemangioma secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hemangioma secondary prevention

CDC on Hemangioma secondary prevention

Hemangioma secondary prevention in the news

Blogs on Hemangioma secondary prevention

Directions to Hospitals Treating Hemangioma

Risk calculators and risk factors for Hemangioma secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

  • Bleeding (especially if the hemangioma is injured)
  • Problems with breathing and eating
  • Psychological problems, from skin appearance
  • Secondary infections and sores
  • Visible changes in the skin
  • Vision problems (amblyopia, strabismus)

References


Template:WikiDoc Sources